国泰君安创新医药混合发起C (021987.jj ) 上海国泰海通证券资产管理有限公司申 | 基金类型混合型成立日期2024-08-26总资产规模 (2025-12-31) 基金净值0.8959元 (2026-02-11) 基金经理李子波管理费用率1.20%管托费用率0.20% (2025-12-22) 成立以来分红再投入年化收益率12.94% (1833 / 9092) |
| 相关基金: | 主从基金: 国泰海通创新医药混合发起A |
| 备注 (0): | 双击编辑备注 |
国泰君安创新医药混合发起C(021987) - 基金对比
最后更新于：2026-02-11
非全收益率指数点位的计算不包含分红再投入，所以理论上指数基金的分红再投入收益率高于其对应的指数点位涨幅。
加载中......
| 日期 | 国泰君安创新医药混合发起C - 相对起始点分红再投入收益率 | 沪深300 - 相对起始点收益率 |
|---|---|---|
| 2026-02-11 | 19.44% | 38.49% |
| 2026-02-10 | 19.54% | 38.79% |
| 2026-02-09 | 18.05% | 38.64% |
| 2026-02-06 | 16.72% | 36.42% |
| 2026-02-05 | 17.29% | 37.21% |
| 2026-02-04 | 16.84% | 38.04% |
| 2026-02-03 | 15.97% | 36.91% |
| 2026-02-02 | 14.06% | 35.32% |
| 2026-01-30 | 18.20% | 38.27% |
| 2026-01-29 | 19.20% | 39.66% |
| 2026-01-28 | 20.56% | 38.61% |
| 2026-01-27 | 21.50% | 38.25% |
| 2026-01-26 | 22.06% | 38.29% |
| 2026-01-23 | 24.28% | 38.15% |
| 2026-01-22 | 23.06% | 38.78% |
| 2026-01-21 | 24.97% | 38.76% |
| 2026-01-20 | 24.22% | 38.64% |
| 2026-01-19 | 26.69% | 39.09% |
| 2026-01-16 | 28.93% | 39.02% |
| 2026-01-15 | 29.44% | 39.59% |
| 2026-01-14 | 31.37% | 39.31% |
| 2026-01-13 | 31.85% | 39.87% |
| 2026-01-12 | 27.93% | 40.72% |
| 2026-01-09 | 29.13% | 39.81% |
| 2026-01-08 | 27.33% | 39.19% |
| 2026-01-07 | 27.57% | 40.33% |
| 2026-01-06 | 23.52% | 40.74% |
| 2026-01-05 | 22.49% | 38.60% |
| 2025-12-31 | 18.53% | 36.02% |
| 2025-12-30 | 19.28% | 36.65% |
| 2025-12-29 | 19.50% | 36.30% |
| 2025-12-26 | 20.88% | 36.82% |
| 2025-12-25 | 21.34% | 36.39% |
| 2025-12-24 | 21.26% | 36.14% |
| 2025-12-23 | 21.81% | 35.75% |
| 2025-12-22 | 21.61% | 35.48% |
| 2025-12-19 | 21.68% | 34.21% |
| 2025-12-18 | 20.22% | 33.76% |
| 2025-12-17 | 19.97% | 34.55% |
| 2025-12-16 | 18.97% | 32.13% |
| 2025-12-15 | 20.73% | 33.73% |
| 2025-12-12 | 23.70% | 34.58% |
| 2025-12-11 | 23.70% | 33.74% |
| 2025-12-10 | 23.82% | 34.90% |
| 2025-12-09 | 23.58% | 35.09% |
| 2025-12-08 | 24.20% | 35.78% |
| 2025-12-05 | 25.04% | 34.69% |
| 2025-12-04 | 24.94% | 33.57% |
| 2025-12-03 | 24.02% | 33.12% |
| 2025-12-02 | 25.06% | 33.80% |